Environmental cadmium and lead exposures and hearing loss in U.S. adults: The National Health and Nutrition Examination Survey, 1999 to 2004

Environmental Health Perspectives

Volumn 120, Issue 11, 2012, Pages 1544-1550

  Choi, Yoon Hyeong ^a   Hu, Howard ^a   Mukherjee, Bhramar ^a   Miller, Josef ^b   Park, Sung Kyun ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cadmium; Epidemiology; Hearing; Lead; NHANES

Indexed keywords

CADMIUM; LEAD;

ADULT; AGE; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; AUDIOMETRY; AUDITORY THRESHOLD; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EDUCATION; ENVIRONMENTAL EXPOSURE; ETHNIC GROUP; FEMALE; GENDER; HEARING IMPAIRMENT; HUMAN; MALE; MASS SPECTROMETRY; NOISE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADULT; AGED; AUDIOMETRY, PURE-TONE; CADMIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HEARING LOSS; HUMANS; LEAD; LINEAR MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; RISK FACTORS; SPECTROPHOTOMETRY, ATOMIC; UNITED STATES; YOUNG ADULT;

ANIMALIA;

EID: 84868572431     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104863     Document Type: Article

References (49)

1. Agency for Toxic Substances and Disease Registry. 2010a. Case Studies in Environmental Medicine. Cadmium Toxicity. Atlanta, GA:Centers for Disease Control and Prevention. Available: http://www.atsdr.cdc.gov/csem/csem.asp?csem= 6&po= 0 [accessed 13 December 2011].
2. Agency for Toxic Substances and Disease Registry. 2010b. Case Studies in Environmental Medicine. Lead Toxicity. Atlanta, GA: Centers for Disease Control and Prevention. Available: http://www.atsdr.cdc.gov/csem/csem.asp?csem= 6&po= 0 [accessed 13 December 2011].
3. Agrawal Y, Platz EA, Niparko JK. 2009. Risk factors for hearing loss in U.S. adults: data from the National Health and Nutrition Examination Survey, 1999 to 2002. Otol Neurotol 30:139-145.
4. Alfvén T, Järup L, Elinder C-G. 2002. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect 110:699-702.
5. Bainbridge KE, Hoffman HJ, Cowie CC. 2008. Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Ann Intern Med 149:1-10.
6. CDC (Centers for Disease Control and Prevention). 2001a. Laboratory Procedure Manual: Blood Cadmium and Lead, NHANES 1999-2000. Method No. 1090A/02-OD. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_99_00/lab06_met_lead_and_cadmium.pdf [accessed 7 April 2011].
7. CDC (Centers for Disease Control and Prevention). 2001b. Laboratory Procedure Manual: Blood Cadmium and Lead, NHANES 2001-2002. Method No. 1090A/02-OD. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/l06_b_met_lead_and_cadmium.pdf [accessed 1 April 2011].
8. CDC (Centers for Disease Control and Prevention). 2004a. Laboratory Procedure Manual: Lead, Cadmium, and Mercury in Whole Blood, NHANES 2003-2004. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l06_c_met_pb_cd_hg.pdf [accessed 1 April 2011].
9. CDC (Centers for Disease Control and Prevention). 2004b. NHANES 1999-2000 Data Release-May 2004: Frequencies of Blood Lead and Cadmium (Lab06). Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_99_00/lab06_frq.pdf [accessed 1 April 2011].
10. CDC (Centers for Disease Control and Prevention). 2005. National Health and Nutrition Examination Survey: 1999-2000 Data Documentation, Codebook, and Frequencies. Audiometry (AUX1). Available: http://www.cdc.gov/nchs/nhanes/nhanes1999-2000/AUX1.htm [accessed 24 October 2010].
11. CDC (Centers for Disease Control and Prevention). 2007a. National Health and Nutrition Examination Survey, 2007-2008. Overview. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/overviewbrochure_0708.pdf [accessed 13 December 2011].
12. CDC (Centers for Disease Control and Prevention). 2007b. NHANES 1999-2000 Data Documentation. Last Revised: September 2007. Lab 6: Blood Lead and Cadmium. Available: http://www.nber.org/nhanes/1999_2000/downloads/lab06_doc.pdf [accessed 13 December 2011].
13. CDC (Centers for Disease Control and Prevention). 2007c. NHANES 2001-2002 Data Release Frequencies: Blood Lead and Cadmium (L06_B), May 2007. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/l06_b_frq.pdf [accessed 1 April 2011].
14. Chang T-Y, Liu C-S, Huang K-H, Chen R-Y, Lai J-S, Bao B-Y. 2011. High-frequency hearing loss, occupational noise exposure, and hypertension: a cross-sectional study in male workers. Environ Health 10:35-42.
15. Chen X, Zhu G, Jin T, Lei L, Liang Y. 2011. Bone mineral density is related with previous renal dysfunction caused by cadmium exposure. Environ Toxicol Pharmacol 32:46-53.
16. Choi Y-H, Hu H, Tak S, Mukherjee B, Park SK. 2012. Occupational noise exposure assessment using O*NET and its application to a study of hearing loss in the U.S. general population. Occup Environ Med 69:176-183.
17. Department of Health and Human Services. 2005. Third National Report on Human Exposure to Environmental Chemicals. Atlanta, GA:Centers for Disease Control and Prevention
18. Discalzi G, Fabbro D, Meliga F, Mocellini A, Capellaro F. 1993. Effects of occupational exposure to mercury and lead on brainstem auditory evoked potentials. Int J Psychophysiol 14:21-25.
19. Ercal N, Gurer-Orhan H, Aykin-Burns N. 2001. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 1:529-539.
20. Forst LS, Freels S, Persky V. 1997. Occupational lead exposure and hearing loss. J Occup Environ Med 39:658-660.
21. Gollenberg AL, Hediger ML, Lee PA, Himes JH, Buck Louis GM. 2010. Association between lead and cadmium and reproductive hormones in peripubertal U.S. girls. Environ Health Perspect 118:1782-1787.
22. Guallar E, Silbergeld EK, Navas-Acien A, Malhotra S, Astor BC, Sharrett AR, et al. 2006. Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function. Am J Epidemiol 163:700-708
23. Güneri EA, Ada E, Ceryan K, Güneri A. 1996. High-resolution computed tomographic evaluation of the cochlear capsule in otosclerosis: relationship between densitometry and sensorineural hearing loss. Ann Otol Rhinol Laryngol 105:659-664.
24. Hosmer DW, Lemeshow S. 1992. Confidence interval estimation of interaction. Epidemiology 3:452-456.
25. Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss ST, et al. 1996. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA 275:1171-1176.
26. Hu H, Shih R, Rothenberg S, Schwartz BS. 2007. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect 115:455-462.
27. Ikeda N, Murray CJL, Salomon JA. 2009. Tracking population health based on self-reported impairments: trends in the prevalence of hearing loss in U.S. adults, 1976-2006. Am J Epidemiol 170:80-87.
28. Järup L, Berglund M, Elinder C-G, Nordberg G, Vahter M. 1998. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J Work Environ Health 24:1-51.
29. Jones LG, Prins J, Park S, Walton JP, Luebke AE, Lurie DI. 2008. Lead exposure during development results in increased neurofilament phosphorylation, neuritic beading, and temporal processing deficits within the murine auditory brainstem. J Comp Neurol 506:1003-1017.
30. Kim R, Rotnitzky A, Sparrow D, Weiss ST, Wager C, Hu H. 1996. A longitudinal study of low-level lead exposure and impairment of renal function. JAMA 275:1177-1181.
31. Kim S-J, Jeong H-J, Myung N-Y, Kim M-c, Lee J-H, So H-S, et al. 2008. The protective mechanism of antioxidants in cadmium-induced ototoxicity in vitro and in vivo. Environ Health Perspect 116:854-862.
32. Knol MJ, and VanderWeele TJ. 2012. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol 41:514-520.
33. Lasky RE, Maier MM, Snodgrass EB, Hecox KE, Laughlin NK. 1995. The effects of lead on otoacoustic emissions and auditory evoked potentials in monkeys. Neurotoxicol Teratol 17:633-644.
34. Monsell EM, Cody DD, Bone HG, Divine GW, Windham JP, Jacobson GP, et al. 1995. Hearing loss in Paget's disease of bone: the relationship between pure-tone thresholds and mineral density of the cochlear capsule. Hear Res 83:114-120.
35. Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. 2005. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 165:2155-2161.
36. Navas-Acien A, Tellez-Plaza M, Guallar E, Muntner P, Silbergeld E, Jaar B, et al. 2009. Blood cadmium and lead and chronic kidney disease in U.S. adults: a joint analysis. Am J Epidemiol 170:1156-1164.
37. Nordberg G, Nogawa K, Nordberg M. 2007. Cadmium. In: Handbook on the Toxicology of Metals, (NordbergG, FowlerB, NordbergM, eds). Amsterdam:Elsevier, 446-486.
38. Ozcaglar H, Agirdir B, Dinc O, Turhan M, Kilinçarslan S, Oner G. 2001. Effects of cadmium on the hearing system. Acta Otolaryngol 121:393-397.
39. Park SK, Elmarsafawy S, Mukherjee B, Spiro A III, Vokonas PS, Nie H, et al. 2010. Cumulative lead exposure and age-related hearing loss: the VA Normative Aging Study. Hear Res 269:48-55.
40. Pleis JR, Lethbridge-Cejku M. 2006. Summary health statistics for U.S. adults: National Health Interview Survey, 2005. Vital Health Stat 10 242:1-157.
41. Sabolic' I. 2006. Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol 104:107-114.
42. Schwartz GG, Il'yasova D, Ivanova A. 2003. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diebetes Care 26:468-470.
43. Schwartz J, Otto D. 1991. Lead and minor hearing impairment. Arch Environ Health 46:300-305.
44. Shargorodsky J, Curhan SG, Henderson E, Eavey R, Curhan GC. 2011. Heavy metals exposure and hearing loss in U.S. adolescents. Arch Otolaryngol Head Neck Surg 137:1183-1189.
45. Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, GuallarE. 2008. Cadmium exposure and hypertension in the 1999-2004 National Health and Nutrition Examination Survey (NHANES). Environ Health Perspect 116:51-56.
46. Vaziri ND, Khan M. 2007. Interplay of reactive oxygen species and nitric oxide in the pathogenesis of experimental lead-induced hypertension. Clin Exp Pharmacol Physiol 34:920-925.
47. Vilayur E, Gopinath B, Harris DC, Burlutsky G, McMahon CM, Mitchell P. 2010. The association between reduced GFR and hearing loss: a cross-sectional population-based study. Am J Kidney Dis 56:661-669.
48. Yamamura K, Terayama K, Yamamoto N, Kohyama A, KishiR. 1989. Effects of acute lead acetate exposure on adult guinea pigs: Electrophysiological study of the inner ear. Fundam Appl Toxicol 13:509-515.
49. Yueh B, Shapiro N, MacLean CH, Shekelle PG. 2003. Screening and management of adult hearing loss in primary care: scientific review. JAMA 289:1976-1985.